179 related articles for article (PubMed ID: 36050834)
41. Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells.
Liu W; Rabinovich A; Nash Y; Frenkel D; Wang Y; Youdim MBH; Weinreb O
Neuropharmacology; 2017 Feb; 113(Pt A):445-456. PubMed ID: 27984078
[TBL] [Abstract][Full Text] [Related]
42. BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-β Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAβPPα.
Owens L; Bracewell J; Benedetto A; Dawson N; Gaffney C; Parkin E
J Alzheimers Dis; 2022; 86(3):1201-1220. PubMed ID: 35180123
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease.
Mishra CB; Manral A; Kumari S; Saini V; Tiwari M
Bioorg Med Chem; 2016 Aug; 24(16):3829-41. PubMed ID: 27353888
[TBL] [Abstract][Full Text] [Related]
44. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease.
Rastegari A; Safavi M; Vafadarnejad F; Najafi Z; Hariri R; Bukhari SNA; Iraji A; Edraki N; Firuzi O; Saeedi M; Mahdavi M; Akbarzadeh T
Mol Divers; 2022 Feb; 26(1):409-428. PubMed ID: 34273065
[TBL] [Abstract][Full Text] [Related]
46. In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones.
Lee S; Youn K; Lim G; Lee J; Jun M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932100
[TBL] [Abstract][Full Text] [Related]
47. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
48. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
[TBL] [Abstract][Full Text] [Related]
49. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK
Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043
[TBL] [Abstract][Full Text] [Related]
50. Development of Activity Rules and Chemical Fragment Design for In Silico Discovery of AChE and BACE1 Dual Inhibitors against Alzheimer's Disease.
Bao LQ; Baecker D; Mai Dung DT; Phuong Nhung N; Thi Thuan N; Nguyen PL; Phuong Dung PT; Huong TTL; Rasulev B; Casanola-Martin GM; Nam NH; Pham-The H
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110831
[TBL] [Abstract][Full Text] [Related]
51. Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes.
Dai R; Sun Y; Su R; Gao H
Biomed Pharmacother; 2022 Oct; 154():113576. PubMed ID: 36007279
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and in vitro evaluation of vanillin derivatives as multi-target therapeutics for the treatment of Alzheimer's disease.
Blaikie L; Kay G; Kong Thoo Lin P
Bioorg Med Chem Lett; 2020 Nov; 30(21):127505. PubMed ID: 32822761
[TBL] [Abstract][Full Text] [Related]
53. Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis.
Kanhed AM; Sinha A; Machhi J; Tripathi A; Parikh ZS; Pillai PP; Giridhar R; Yadav MR
Bioorg Chem; 2015 Aug; 61():7-12. PubMed ID: 26042530
[TBL] [Abstract][Full Text] [Related]
54. Dual targeting of acetylcholinesterase and tau aggregation: Design, synthesis and evaluation of multifunctional deoxyvasicinone analogues for Alzheimer's disease.
Manzoor S; Gabr MT; Rasool B; Pal K; Hoda N
Bioorg Chem; 2021 Nov; 116():105354. PubMed ID: 34562674
[TBL] [Abstract][Full Text] [Related]
55. Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents.
Patel DV; Patel NR; Kanhed AM; Patel SP; Sinha A; Kansara DD; Mecwan AR; Patel SB; Upadhyay PN; Patel KB; Shah DB; Prajapati NK; Murumkar PR; Patel KV; Yadav MR
ACS Chem Neurosci; 2019 Aug; 10(8):3635-3661. PubMed ID: 31310717
[TBL] [Abstract][Full Text] [Related]
56. Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease.
Asadi M; Ebrahimi M; Mohammadi-Khanaposhtani M; Azizian H; Sepehri S; Nadri H; Biglar M; Amanlou M; Larijani B; Mirzazadeh R; Edraki N; Mahdavi M
Chem Biodivers; 2019 Nov; 16(11):e1900370. PubMed ID: 31523926
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Pan W; Wang K; Ma Q; Yu L; Yang Y; Bai P; Leng C; Xu Q; Li X; Tan Z; Liu W
Eur J Med Chem; 2017 Apr; 130():379-392. PubMed ID: 28279845
[TBL] [Abstract][Full Text] [Related]
58. Targeting the β secretase BACE1 for Alzheimer's disease therapy.
Yan R; Vassar R
Lancet Neurol; 2014 Mar; 13(3):319-29. PubMed ID: 24556009
[TBL] [Abstract][Full Text] [Related]
59. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis, and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Sang ZP; Qiang XM; Li Y; Wu B; Zhang H; Zhao MG; Deng Y
Chem Biol Drug Des; 2015 Nov; 86(5):1168-77. PubMed ID: 25941042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
